351. [siRNA-mediated inhibition of ErbB2 expression and its effect on breast cancer cell growth].
- Author
-
Jiang K, Yang ZH, Wang ZY, Xu XJ, Cheng L, Zhang H, Han YJ, and Ye QN
- Subjects
- Breast Neoplasms genetics, Cell Line, Tumor, Cell Proliferation drug effects, Down-Regulation drug effects, Female, Gene Transfer Techniques instrumentation, Genetic Vectors, Humans, RNA Interference, Receptor, ErbB-2 genetics, Transfection methods, Breast Neoplasms pathology, RNA, Small Interfering genetics, RNA, Small Interfering pharmacology, Receptor, ErbB-2 biosynthesis
- Abstract
Aim: To construct a vector of ErbB2 small interfering RNA(siRNA), and to investigate its effect on ErbB2 expression and the growth of ZR75-1 breast cancer cells., Methods: Two ErbB2-siRNAs were designed and inserted into the pSliencer 2.1-U6 neo vector. After confirmed by restriction and DNA sequencing, siRNA vectors were co-transfected with the FLAG-ErbB2 expression vector into human embryonic kidney 293T cells, or transfected into SKBR3 and ZR75-1 breast cancer cells. The effects of siRNAs on the expression of ErbB2 were identified by Western blot and the proliferation of ZR75-1 cells was repressed., Results: Two siRNAs could effectively inhibit the expression of exogenous and endogenous ErbB2 proteins, and could repress the growth of ZR75-1 cells., Conclusion: ErbB2 siRNAs effectively inhibit the expression of ErbB2, thus repressing the growth of ZR75-1 cells.
- Published
- 2011